SB
SPRUCE BIOSCIENCES, INC.
SEC filingBiotechnology · South San Francisco, CA
Amount raised$50Msold at filing
Total offering$50M
Investors in the raise21count reported to the SEC
FiledOct 17, 2025first sale Oct 9, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Kirk WaysDirector
Javier SzwarcbergExecutive Officer, Director
Simpson CamillaDirector
Percival Barretto-KoDirector
Tiba AynechiDirector
Samir GharibExecutive Officer
Bali MuralidharDirector
Michael GreyExecutive Officer, Director
Daniel SpiegelmanDirector
Executive officers, directors and promoters as listed on the Form D.